Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 8, 2012, Pages 1272-1284

  Torle ́n, Klara ^a,b   Kalantar Zadeh, Kamyar ^b,c,d   Molnar, Miklos Z ^b,d,e   Vashistha, Tania ^b   Mehrotra, Rajnish ^f  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e SEMMELWEIS UNIVERSITY   (Hungary)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM;

AGED; ALL CAUSE MORTALITY; ARTICLE; ATTRIBUTABLE RISK; CARDIOVASCULAR MORTALITY; CAUSE SPECIFIC MORTALITY; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; POTASSIUM BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DOWN-REGULATION; FEMALE; HUMANS; HYPOKALEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PERITONEAL DIALYSIS; POTASSIUM; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84864801453     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00960112     Document Type: Article

References (27)

1. National Institutes of Health, US Renal Data System: USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, 2011
2. Agarwal R: Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol 4: 830-837, 2009
3. GrossML, Ritz E:Hypertrophy and fibrosis in the cardiomyopathy of uremia-beyond coronary heart disease. Semin Dial 21: 308-318, 2008
4. Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR, Kalantar-Zadeh K: Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol 6: 1041-1048, 2011
5. Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CJ, Whellan D, Sharma K: A1C and survival in maintenance hemodialysis patients. Diabetes Care 30: 1049-1055, 2007
6. Foley RN, Gilbertson DT, Murray T, Collins AJ: Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 365: 1099-1107, 2011
7. Breidthardt T, McIntyre CW: Dialysis-induced myocardial stunning: The other side of the cardiorenal syndrome. Rev Cardiovasc Med 12: 13-20, 2011
8. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysisinduced cardiac injury: Determinants and associated outcomes. Clin J Am Soc Nephrol 4: 914-920, 2009
9. Selby NM, McIntyre CW: Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int 31: 27-33, 2011
10. Szeto CC, Chow KM, Kwan BC, Leung CB, Chung KY, Law MC, Li PK: Hypokalemia in Chinese peritoneal dialysis patients: Prevalence and prognostic implication. Am J Kidney Dis 46: 128-135, 2005
11. ChuangYW, ShuKH, Yu TM, ChengCH, ChenCH:Hypokalaemia: An independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 24: 1603-1608, 2009
12. Kant AK, Graubard BI, Kumanyika SK: Trends in black-white differentials in dietary intakes of U.S. adults, 1971-2002. Am J Prev Med 32: 264-272, 2007
13. Greenland S: Applications of stratified analysis methods. In: Modern Epidemiology, 2nd ed., edited by Rothman K, Greenland S, Philadelphia, Lippincott-Raven, 1998
14. Spital A, Sterns RH: Potassium supplementation via the dialysate in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 6: 173-176, 1985
15. Tziviskou E, Musso C, Bellizzi V, Khandelwal M, Wang T, Savaj S, Oreopoulos DG: Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: One center's experience and review of the literature. Int Urol Nephrol 35: 429-434, 2003
16. Jung JY, Chang JH, Lee HH, Chung W, Kim S: De novo hypokalemia in incident peritoneal dialysis patients: A 1-year observational study. Electrolyte Blood Press 7: 73-78, 2009
17. Oreopoulos DG, Khanna R, Williams P, Vas SI: Continuous ambulatory peritoneal dialysis-1981. Nephron 30: 293-303, 1982
18. Khan AN, Bernardini J, Johnston JR, Piraino B: Hypokalemia in peritoneal dialysis patients. Perit Dial Int 16: 652, 1996
19. Clausen T, Everts ME: Regulation of the Na, K-pump in skeletal muscle. Kidney Int 35: 1-13, 1989
20. Hundal HS, Marette A, Mitsumoto Y, Ramlal T, Blostein R, Klip A: Insulin induces translocation of the alpha 2 and beta 1 subunits of the Na+/K(+)-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 267: 5040-5043, 1992
21. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482, 1990
22. Iseki K, Uehara H, Nishime K, Tokuyama K, Yoshihara K, Kinjo K, Shiohira Y, Fukiyama K: Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. AmJ KidneyDis 28: 541-548, 1996
23. Szeto CC, Chow VC, Chow KM, Lai RW, Chung KY, Leung CB, Kwan BC, Li PK: Enterobacteriaceae peritonitis complicating peritoneal dialysis: A reviewof 210 consecutive cases. Kidney Int 69: 1245-1252, 2006
24. Murata GH, Fox L, Tzamaloukas AH: Predicting the course of peritonitis in patients receiving continuous ambulatory peritoneal dialysis. Arch Intern Med 153: 2317-2321, 1993
25. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2: 999-1007, 2007
26. Longenecker JC, Coresh J, KlagMJ, LeveyAS, Martin AA, FinkNE, Powe NR: Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 11: 520-529, 2000
27. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J AmSoc Nephrol 12: 2158-2162, 2001